HOME >> BIOLOGY >> NEWS
Experimental cancer drugs may halt events that lead to cardiac hypertrophy and heart failure

(Philadelphia, PA) The events that lead to cardiac hypertrophy, the enlargement of heart muscle cells, may be stopped by histone deacetylase (HDAC) inhibitors, a class of therapeutic agents currently under development as cancer drugs, according to researchers at the University of Pennsylvania School of Medicine. Cardiac hypertrophy is one of the leading causes of congestive heart failure, the most common diagnosis given for discharged hospital patients in the United States.

In the September issue of Journal of Clinical Investigation, the Penn researchers suggest novel genetic causes for and new therapeutic agents against cardiac hypertrophy and heart failure. Furthermore, the researchers demonstrate that anti-HDAC drugs can block the development of hypertrophy in animal models.

"In our studies, we determined that valproic acid, an HDAC inhibitor used to treat seizure disorders, is effective in preventing heart muscle cells from enlarging," said Jonathan A. Epstein, MD, Associate Professor in the division of Cardiovascular Medicine within Penn's Department of Medicine. "In recent years, drug companies have also begun developing more advanced HDAC inhibitors to treat cancer. These HDAC inhibitors may be among the first known medications to prevent cardiac hypertrophy."

Cardiac hypertrophy can be a healthy physiological response to events, such as aerobic exercise, where heart cells grow larger like any other well-conditioned muscle. Pathological hypertrophy, however, may result from genetic mutation or, most commonly, from the consequences of an unhealthy cardiovascular system.

"The exertion of pushing blood against high resistance in the setting of high blood pressure or overcompensation for heart muscle lost during a heart attack can cause heart muscle cells to enlarge," said Epstein. "While it might be helpful at first, hypertrophy can increase the stress placed on the heart and begin a downward spiral of events that ultimately leads
'"/>

Contact: Greg Lester
lesterg@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
15-Sep-2003


Page: 1 2

Related biology news :

1. Experimental drug shown to block mutant protein causing blood disease
2. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
3. Experimental smallpox vaccine protects against monkeypox in nonhuman primates
4. Experimental Biology 2004 - Translating the Genome
5. Experimental Biology 2004 meets in Washington, D.C. April 17-21
6. Experimental hantavirus vaccine elicits strong antibody response in primates
7. Experimental Biology 2003 meets in San Diego April 11-15
8. Experimental Biology 2003 meets in San Diego April 11-15
9. Experimental gene switch increases lifespan with no ill effects
10. Experimental therapy stops allergic reactions in mice
11. APS awards 44 minority travel fellowships to the Experimental Biology 2002 meeting

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/6/2019)... ... 06, 2019 , ... NDA Partners Chairman Carl Peck, ... with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert in ... joined the firm as an Expert Consultant. , Dr. Stanski has served in ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... solutions for drugs, biologics, gene therapies, and consumer health products, today announced it ... Hotel Sofia, Barcelona, Spain on Nov. 12 – 14, 2019. , On Wednesday, ...
(Date:11/2/2019)... , ... November 01, 2019 , ... Stay on top ... and medical device industries. Access to all webinars is free, so be sure to ... your field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL ...
Breaking Biology News(10 mins):
(Date:11/27/2019)... ... 2019 , ... Silony Medical, a medical technology company producing ... in the UK. The procedure was performed in the UK’s largest trauma center, ... Dr. Alexander Montgomery. The surgery, which took place on July 22, 2019, was ...
(Date:11/19/2019)... ... 19, 2019 , ... Supercomputing Conference – Cirrascale Cloud ... Autonomous Vehicle , Medical Imaging, and Natural Language Processing (NLP) workflows, today ... Poplar® software stack as part of its bare-metal cloud service offerings. In addition ...
(Date:11/12/2019)... ... November 12, 2019 , ... ... new Director of Forensic Genealogy, Melinde Lutz Byrne, to the organization. Byrne’s team ... ultimately provide investigative leads to law enforcement through proven genealogy and DNA analysis ...
(Date:11/6/2019)... ... November 06, 2019 , ... LeadingBiotech ,?an exclusive event ... its East/West CEO conference to be held January 11-12, 2020 at ... off the week of the J.P. Morgan Healthcare Conference and other biotech industry ...
Breaking Biology Technology:
Cached News: